ABT logo Abbott Laboratories +
Abbott Laboratories
+

Abbott Laboratories Overview

Company: Abbott Laboratories
CEO: Robert Ford
Founded: 1888
Symbol: ABT
Exchange: NYSE
Industry: Medical - Devices
Sector: Healthcare
About

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Continue reading...

Abbott Laboratories (ABT)

  • Stock Price
  • Volume
85.58 -20.19 -19.08%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Abbott Laboratories annual revenue was $44.33 B in 2025.

Net Income

Abbott Laboratories annual net income was $6.52 B in 2025.

Employees

Abbott Laboratories annual employee count was 115,000 in 2025.

Revenue by Segment

Abbott Laboratories’s revenue by segment: Diagnostic Products: $8.94 B, Established Pharmaceutical Products: $5.54 B, Medical Devices: $21.39 B and Nutritional Products: $8.45 B in 2025.

Revenue by Region

Abbott Laboratories’s revenue by region: C [H]: $1.87 B, C [N]: $1.91 B, D [E]: $2.76 B, I [N]: $1.87 B, J [P]: $1.48 B, Non-US: $15.98 B and UNITED STATES: $17.13 B in 2025.

Executive Salary

Philip P. Boudreau , Executive Vice President, Finance and Chief Fin...

Revenue per Employee

Abbott Laboratories revenue per employee was $385.46 K in 2025.

Profit per Employee

Abbott Laboratories profit per employee was $56.73 K in 2025.

Income Statement

Operating Income

Abbott Laboratories annual operating income was $8.05 B in 2025.

Research & Development

Abbott Laboratories annual research & development expense was $2.96 B in 2025.

Tax Rate (%)

Abbott Laboratories annual Tax Rate was 23.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

Abbott Laboratories annual total assets was - in 2025.

Total Liabilities

Abbott Laboratories annual total liabilities was $641.00 M in 2025.

Capital Expenditure

Abbott Laboratories annual capital expenditures was - in 2025.

Ratios

Return on Equity (ROE)

Abbott Laboratories annual return on equity(ROE) was 0.00% in 2025.

Return on Assets (ROA)

Abbott Laboratories annual return on assets(ROA) was 0.00% in 2025.

Debt to Equity

Abbott Laboratories annual debt to equity was 28.90% in 2025.

Profitability

Gross Profit Margin (%)

Abbott Laboratories annual gross profit margin was 55.51% in 2025.

Operating Income Margin (%)

Abbott Laboratories annual operating income margin was 18.16% in 2025.

Net Income Margin (%)

Abbott Laboratories annual net income margin was 14.72% in 2025.

Earning Per Share

Abbott Laboratories annual earning per share was $3.73 in 2025.

EBITDA

Abbott Laboratories annual EBITDA was $11.33 B in 2025.

Free Cash Flow (FCF)

Abbott Laboratories annual free cash flow(FCF) was $9.57 B in 2025.

Valuation

Enterprise value

Abbott Laboratories annual enterprise value was - in 2025.

Enterprise value to Revenue

Abbott Laboratories annual enterprise value to revenue was 0.00 in 2025.

Enterprise value to EBITDA

Abbott Laboratories annual enterprise value to EBITDA was 0.00 in 2025.

Competitors’ Revenue

Frequently Asked Questions

When was Abbott Laboratories founded?

Abbott Laboratories was founded on 1888, which makes the company 138 years old.

Sign up for free to view

Who is the CEO of Abbott Laboratories?

Robert Ford is the CEO of Abbott Laboratories.

What industry and sector is Abbott Laboratories in?

Abbott Laboratories operates in the Medical - Devices industry and the Healthcare sector.

What are Abbott Laboratories's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000001800
  • SIC (Standard Industrial Classification): 2834
  • ISIN (International Securities Identification Number): US0028241000

Sign up for free to view

How many employees does Abbott Laboratories have?

Abbott Laboratories has 115,000 employees.

What is the revenue of Abbott Laboratories?

In fiscal year 2025, Abbott Laboratories generated a revenue of $44.33 Billion.

What is the net income of Abbott Laboratories?

In fiscal year 2025, Abbott Laboratories reported a net income of $6.52 Billion.

What is Abbott Laboratories's biggest product segment?

Medical Devices is Abbott Laboratories's biggest product segment, representing 48.27% of its total revenue.

When was Abbott Laboratories listed on the stock exchange?

Abbott Laboratories went public on Mar 17, 1980, through its Initial Public Offering (IPO), and it has been 46 years since then.

Sign up for free to view

What is the ticker symbol of Abbott Laboratories, and where is it listed?

Abbott Laboratories's ticker symbol is ABT, and the company is listed on the NYSE stock market exchange.

What is Abbott Laboratories's current stock price?

Abbott Laboratories's current stock price is $85.58 as of May 30, 2026.

What is Abbott Laboratories's market capitalization?

As of , Abbott Laboratories's market cap is .

What is Abbott Laboratories's ranking in the world?

Ranked #12among 2,804 companies based on market cap.

Who are the top competitors of Abbott Laboratories?

Competitors of Abbott Laboratories include Stryker Corporation, Boston Scientific Corporation and DexCom, and more.

Related company

Submit feedback to Bullfincher